2018
DOI: 10.1016/j.soard.2018.05.026
|View full text |Cite
|
Sign up to set email alerts
|

Biphasic changes in angiopoietin-like 8 level after laparoscopic sleeve gastrectomy and type 2 diabetes remission during a 1-year follow-up

Abstract: Elevated baseline ANGPTL8 in participants with diabetes at baseline reflected a link to T2D. Interestingly, the unique biphasic pattern of change in fasting ANGPTL8 post-LSG, occurred only in people with diabetes, suggesting ANGPTL8's potential role in T2D remission.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 35 publications
2
6
0
Order By: Relevance
“…Post-LSG participants displayed a rapid improvement in various clinical parameters. LSG ameliorated FPG, A1C, c-peptide, insulin resistance (iHOMA-IR), and β-cell activity (iHOMA2% β), indicating T2D remission (previously reported [20]). There was a gradual decline in weight loss post-LSG that was reflected by BMI, excess weight loss (%EWL), and body fat (%BF) in people with morbid obesity, with and without T2D, which was significant after one year of LSG [20].…”
Section: Lsg Reduces the Risk Of Cvd And Improvessupporting
confidence: 66%
See 4 more Smart Citations
“…Post-LSG participants displayed a rapid improvement in various clinical parameters. LSG ameliorated FPG, A1C, c-peptide, insulin resistance (iHOMA-IR), and β-cell activity (iHOMA2% β), indicating T2D remission (previously reported [20]). There was a gradual decline in weight loss post-LSG that was reflected by BMI, excess weight loss (%EWL), and body fat (%BF) in people with morbid obesity, with and without T2D, which was significant after one year of LSG [20].…”
Section: Lsg Reduces the Risk Of Cvd And Improvessupporting
confidence: 66%
“…LSG ameliorated FPG, A1C, c-peptide, insulin resistance (iHOMA-IR), and β-cell activity (iHOMA2% β), indicating T2D remission (previously reported [20]). There was a gradual decline in weight loss post-LSG that was reflected by BMI, excess weight loss (%EWL), and body fat (%BF) in people with morbid obesity, with and without T2D, which was significant after one year of LSG [20]. Lipid metabolism improved significantly post-LSG, and VLDL levels dropped significantly after 6 months (0:48 ± 0:07 mM, n = 10, p < 0:05) and 1 year (0:39 ± 0:06 mM, n = 10, p < 0:01) of surgery in people with morbid obesity and T2D.…”
Section: Lsg Reduces the Risk Of Cvd And Improvessupporting
confidence: 66%
See 3 more Smart Citations